Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M L, Damiano"'
Autor:
E, Adams, J, Deutsche, E, Okoroh, S, Owens-McAlister, S, Majumdar, M, Ullman, M L, Damiano, M, Recht, Tina, Willis
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 20(5)
In the hemophilia population, obesity has an adverse effect on health care cost, chronic complications, and joint disease. Although staffs of federally-funded Hemophilia Treatment Centers in the United States (HTCs) anecdotally recognize these outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ced51d490a6388087bcdef7a548cb940
https://pubmed.ncbi.nlm.nih.gov/24629074
https://pubmed.ncbi.nlm.nih.gov/24629074
Publikováno v:
Journal of Pediatric Hematology/Oncology. 15:131-134
Purpose Although intracranial hemorrhage remains a leading cause of death in hemophilia, spinal epidural hematoma is seen rarely. Decompressive laminectomy has a high associated morbidity, and recent reports have suggested that patients can be treate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::252ee21f78e4385169af5bcb5ca74f2c
https://doi.org/10.1097/00043426-199302000-00022
https://doi.org/10.1097/00043426-199302000-00022
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 9(1)
Chronic proliferative synovitis secondary to haemathroses is a major complication in patients with severe haemophilia. Current management strategies include prophylactic infusions of the missing coagulation factor, corticosteroids, synoviorthesis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8b6b50f228baee82ba51425e74123820
https://pubmed.ncbi.nlm.nih.gov/12558781
https://pubmed.ncbi.nlm.nih.gov/12558781
Autor:
M L, Damiano, J J, Hutter
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 6(5)
The experience with immune tolerance (IT) induction therapy for haemophilia patients with inhibitors, instituted during 1990-97 at 17 haemophilia treatment centres in the western United States, was reviewed. IT was instituted in 104 of 139 (75%) of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec35babfee153013d4b7c677bb774d4b
https://pubmed.ncbi.nlm.nih.gov/11012697
https://pubmed.ncbi.nlm.nih.gov/11012697
Publikováno v:
JAMA. 253(8)
Danazol was given orally at a dose of 600 mg/day to six hemophiliacs for eight to 14 weeks. All patients showed a significant decrease in activated partial thromboplastin time (APTT) beginning with the first measurement (two weeks) and persisting unt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e1ca303cc308414607e8b0fc5d8d532
https://pubmed.ncbi.nlm.nih.gov/3968845
https://pubmed.ncbi.nlm.nih.gov/3968845
Publikováno v:
The New England journal of medicine. 311(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6668c79c25c8773dc8453d40cf0a0de1
https://pubmed.ncbi.nlm.nih.gov/6727969
https://pubmed.ncbi.nlm.nih.gov/6727969